7LK9 image
Deposition Date 2021-02-01
Release Date 2021-02-17
Last Version Date 2024-11-20
Entry Detail
PDB ID:
7LK9
Keywords:
Title:
Crystal structure of SARS-CoV-2 RBD-targeting antibody COV107-23 HC + COVD21-C8 LC
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.40 Å
R-Value Free:
0.31
R-Value Work:
0.27
R-Value Observed:
0.27
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:COV107-23 heavy chain
Chain IDs:A (auth: H), C (auth: A), E (auth: C), G (auth: M)
Chain Length:220
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:COVD21-C8 light chain
Chain IDs:B (auth: L), D (auth: B), F (auth: D), H (auth: N)
Chain Length:216
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.
Nat Commun 12 3815 3815 (2021)
PMID: 34155209 DOI: 10.1038/s41467-021-24123-7

Abstact

Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short complementarity-determining region (CDR) H3. Germline-encoded sequence motifs in heavy chain CDRs H1 and H2 have a major function, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, is not clear. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that seem to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. These results advance understanding of the antibody response to SARS-CoV-2.

Legend

Protein

Chemical

Disease

Primary Citation of related structures